These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9885436)

  • 1. Biological significance of heterogeneity in human myeloma cells.
    Ishikawa H; Kawano MM
    Int J Hematol; 1998 Dec; 68(4):363-70. PubMed ID: 9885436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma.
    Ishikawa H; Mahmoud MS; Fujii R; Abroun S; Kawano MM
    Leuk Lymphoma; 2000 Sep; 39(1-2):51-5. PubMed ID: 10975383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells.
    Huang N; Kawano MM; Mahmoud MS; Mihara K; Tsujimoto T; Niwa O; Kuramoto A
    Blood; 1995 Jun; 85(12):3704-12. PubMed ID: 7780154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.
    Fujii R; Ishikawa H; Mahmoud MS; Asaoku H; Kawano MM
    Br J Haematol; 1999 Apr; 105(1):131-40. PubMed ID: 10233376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
    Otsuyama K; Asaoku H; Kawano MM
    Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth mechanism of human myeloma cells by interleukin-6.
    Kawano MM; Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X
    Int J Hematol; 2002 Aug; 76 Suppl 1():329-33. PubMed ID: 12430875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myeloma precursor cells].
    Iwato K; Kawano MM
    Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
    Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
    Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myeloma precursor cells and their differentiation].
    Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):552-6. PubMed ID: 7699884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells.
    Tsuyama N; Ishikawa H; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Taniguchi O; Kawano MM
    Hematology; 2003 Dec; 8(6):409-11. PubMed ID: 14668037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
    Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
    Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenotypic analysis of myeloma cells].
    Mihara K; Harada H; Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cells.
    Okikawa Y; Sakai A; Takimoto Y; Noda M; Imagawa J; Katayama Y; Kuroda Y; Okita H; Fujimura K; Kimura A
    Int J Hematol; 2004 May; 79(4):364-8. PubMed ID: 15218967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively.
    Kawano MM; Mahmoud MS; Ishikawa H
    Br J Haematol; 1997 Oct; 99(1):131-8. PubMed ID: 9359513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells.
    Mihara K
    Int J Hematol; 1996 Apr; 63(3):215-26. PubMed ID: 8936335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells.
    Huang N; Kawano MM; Harada H; Harada Y; Sakai A; Kuramoto A; Niwa O
    Blood; 1993 Dec; 82(12):3721-9. PubMed ID: 8260709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules.
    Ishikawa H; Tsuyama N; Kawano MM
    Int J Hematol; 2003 Aug; 78(2):95-105. PubMed ID: 12953802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
    Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
    Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.